Moots, R., Azevedo, V., Coindreau, J. L., Dörner, T., Mahgoub, E., Mysler, E., . . . Marshall, L. (2017). Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician. Curr Rheumatol Rep.
Chicago Style CitationMoots, Robert, Valderilio Azevedo, Javier L. Coindreau, Thomas Dörner, Ehab Mahgoub, Eduardo Mysler, Morton Scheinberg, i Lisa Marshall. "Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician." Curr Rheumatol Rep 2017.
Cita MLAMoots, Robert, et al. "Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician." Curr Rheumatol Rep 2017.